ICU Medical Inc. (ICUI) Stake Held by Fisher Asset Management LLC
Fisher Asset Management LLC continued to hold its position in ICU Medical Inc. (NASDAQ:ICUI) during the third quarter, Holdings Channel reports. The institutional investor owned 31,000 shares of the company’s stock at the end of the third quarter. Fisher Asset Management LLC’s holdings in ICU Medical were worth $3,918,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Eqis Capital Management Inc. boosted its stake in shares of ICU Medical by 0.7% in the second quarter. Eqis Capital Management Inc. now owns 2,509 shares of the company’s stock worth $283,000 after buying an additional 18 shares during the period. Smith Asset Management Group LP boosted its stake in shares of ICU Medical by 2.3% in the second quarter. Smith Asset Management Group LP now owns 25,782 shares of the company’s stock worth $2,907,000 after buying an additional 590 shares during the period. Moody Aldrich Partners LLC boosted its stake in shares of ICU Medical by 166.4% in the second quarter. Moody Aldrich Partners LLC now owns 11,215 shares of the company’s stock worth $1,264,000 after buying an additional 7,005 shares during the period. Cadence Capital Management LLC boosted its stake in shares of ICU Medical by 14.3% in the second quarter. Cadence Capital Management LLC now owns 6,570 shares of the company’s stock worth $741,000 after buying an additional 820 shares during the period. Finally, Mason Street Advisors LLC bought a new stake in shares of ICU Medical during the second quarter worth approximately $319,000. Institutional investors own 88.41% of the company’s stock.
ICU Medical Inc. (NASDAQ:ICUI) traded up 2.38% during mid-day trading on Tuesday, reaching $150.80. The company had a trading volume of 135,290 shares. ICU Medical Inc. has a one year low of $85.56 and a one year high of $154.80. The firm has a market capitalization of $2.46 billion, a P/E ratio of 43.48 and a beta of 0.30. The firm’s 50-day moving average is $144.48 and its 200-day moving average is $123.31.
ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings results on Wednesday, November 9th. The company reported $1.35 EPS for the quarter, beating the Zacks’ consensus estimate of $1.17 by $0.18. ICU Medical had a return on equity of 10.70% and a net margin of 15.18%. The firm had revenue of $97.11 million for the quarter, compared to analyst estimates of $93.04 million. During the same period last year, the firm posted $1.00 earnings per share. The business’s revenue for the quarter was up 12.9% on a year-over-year basis. On average, equities research analysts anticipate that ICU Medical Inc. will post $4.79 earnings per share for the current fiscal year.
A number of brokerages have recently commented on ICUI. Zacks Investment Research cut ICU Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, November 2nd. Piper Jaffray Cos. reaffirmed a “neutral” rating and issued a $119.00 price target (up from $115.00) on shares of ICU Medical in a research note on Thursday, August 11th.
In other news, Director Richard Md Sherman sold 3,000 shares of ICU Medical stock in a transaction dated Monday, September 19th. The stock was sold at an average price of $122.51, for a total transaction of $367,530.00. Following the sale, the director now directly owns 70,699 shares of the company’s stock, valued at $8,661,334.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert S. Swinney sold 2,025 shares of ICU Medical stock in a transaction dated Monday, November 14th. The shares were sold at an average price of $142.88, for a total value of $289,332.00. Following the sale, the director now directly owns 16,850 shares in the company, valued at $2,407,528. The disclosure for this sale can be found here. Insiders own 15.90% of the company’s stock.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical Inc. (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.